KNOREX LTD. Class A Ordinary Shares (KNRX)

KNOREX Ltd. (NYSE:KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven advertising technology solutions, today announced that it received a notice from NYSE Regulation on May 18, 2026 indicating that the Company is not in compliance with the continued listing standards of NYSE American LLC (“NYSE American” or the “Exchange”). The Company filed a Form 12b-25 (the “NT 20-F”), which extended the due date for the Company’s annual report on Form 20-F for the fiscal year ended December 31, 2025 (the “2025 Form 20-F”) to May 15, 2026. The Company failed to timely file its 2025 Form 20-F by the extended filing due date of May 15, 2026 (the “Filing Delinquency”). The Company is now subject to the procedures and requirements set forth in Section 1007 of the NYSE American Company Guide.

KNOREX Ltd. (NYSE American: KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven advertising technology solutions, today announced major advancements to its KNOREX XPO℠ platform. The update introduces an AI-powered Keyword Optimizer for Google Ads and a sophisticated Machine Learning-based Data-Driven Attribution (DDA) model for Meta, Google, TikTok, and other major native platforms. The enhancements are designed to help advertisers improve return on investment, reduce customer acquisition costs, and drive more efficient campaign performance.

KNOREX Ltd. (NYSE American: KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven programmatic advertising solutions, today announced the full-scale commercial deployment of major enhancements to KNOREX KAIROS™ after more than six months of selective deployments, the Company’s proprietary artificial intelligence decisioning infrastructure powering bid optimization and performance modeling within the KNOREX XPO™ platform.

KNOREX Ltd. (NYSE American: KNRX) ("KNOREX" or the "Company"), a leading provider of AI-driven programmatic advertising solutions, today announced partnering with a performance-driven legal marketing firm to conduct a nationwide campaign designed to connect high-intent individuals with law firms across the U.S. The primary objective was to generate a robust pipeline of qualified leads that convert into signed legal retainers, while maintaining strong cost efficiency and scalable performance.

KNOREX Ltd. (NYSE American: KNRX) ("KNOREX" or the "Company"), a leading provider of AI-driven programmatic advertising solutions, today announced results from a large-scale automotive campaign demonstrating how its unified AI-powered XPO platform converts national digital awareness campaigns into dealership visits at scale.

In a market searching for asymmetric upside, ENDRA Life Sciences (NASDAQ: NDRA) is quietly building one of the more compelling dual-engine growth narratives in the small-cap space. The company sits at the intersection of two powerful trends: breakthrough liver imaging technology and next-generation treasury strategy exposure to high-momentum digital assets like HYPE .

KNOREX Ltd. (NYSE American: KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven programmatic online advertising products and solutions, today announced the launch of its agentic AI-ready KNOREX Ads API, designed to serve as a foundational infrastructure layer for AI-native, cross-channel advertising workflows.

KNOREX Ltd. (NYSE American: KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven programmatic online advertising products and solutions, today announced that its Board of Directors has appointed Ning (Michael) Sun as Chief Financial Officer (“CFO”), effective January 22, 2026. The appointment strengthens the Company’s executive leadership team as KNOREX builds internal infrastructure to support its next phase of accelerated growth as a public company.

KNOREX Ltd. (NYSE American: KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven programmatic online advertising products and solutions, today provided a year-end business update highlighting significant commercial progress, including one of the strongest quarters of ad spend transacted through XPO in the Company’s history, as it executes on growth initiatives following its successful NYSE American listing in September. In connection with this update, the Company is also filing a Form 6-K reporting its unaudited interim financial results for the six months ended June 30, 2025.

KNOREX Ltd. (NYSE American: KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven programmatic online advertising products and solutions, today announced it will celebrate the Company’s progress and listing on the New York Stock Exchange by ringing the NYSE Closing Bell at the New York Stock Exchange Building, 11 Wall Street, New York City. KNOREX commenced trading on the NYSE under the ticker symbol “KNRX” on September 29, 2025.

KNOREX Ltd. (NYSE American: KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven programmatic online advertising products and solutions, today announced the launch of a new white-label solutions for a fast-growing live commerce platform that is transforming how creators, sellers, and brands connect online with real-time shoppers across social and streaming channels.

KNOREX Ltd. (NYSE American: KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven programmatic online advertising products and solutions, today announced that its AI-driven cross-channel marketing platform, KNOREX XPOSM, has been successfully deployed by one of Canada’s largest dental care networks to accelerate new patient acquisition across more than 450 clinic locations nationwide.

Integration of KNOREX’s advanced AI with premier providers’ human-verified B2B data empowers marketers to deliver smarter, more precise campaigns at scale

Sunnyvale and Singapore,, Oct. 09, 2025 (GLOBE NEWSWIRE) -- KNOREX Ltd. (NYSE American: KNRX) (“KNOREX” or the “Company”), a leading provider of AI-driven programmatic online advertising products and solutions, today provided a letter to shareholders from its CEO, Justin Choo: